Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey ...

More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older ...

Fresenius Launches Biosimilar Version of AbbVie's Humira The generic drug unit of Germany's Fresenius said on Monday the price for Idacio, its copycat version of Abbvie's top-selling rheumatoid ...

In a change of tack, Britain's healthcare cost watchdog NICE has recommended the use of Bristol-Myers Squibb's rheumatoid arthritis drug Orencia by the state health service following a price discount.